Back to results
US 2010/0137353 A1Published application
Tricyclic compounds as antibacterials
AssigneeGlaxo Group Limited
InventorNeil David Pearson
Life of this patent
Estimating the term…
Abstract
Tricyclic nitrogen containing compounds and their use as antibacterials.
Claims14
A compound of formula (I) or a pharmaceutically acceptable salt thereof:
- wherein:
- Z is CH or N;
- R1a and R1b are independently selected from hydrogen;
- halogen;
- cyano;
- (C1-6)alkyl;
- (C1-6)alkylthio;
- trifluoromethyl;
- trifluoromethoxy;
- carboxy;
- hydroxy optionally substituted with (C1-6)alkyl or (C1-6)alkoxy-substituted(C1 -6)alkyl;
- (C1 -6)alkoxy-substituted(C1-6)alkyl;
- hydroxy (C1-6)alkyl;
- an amino group optionally N-substituted by one or two (C1-6)alkyl, formyl, (C1-6)alkylcarbonyl or (C1-6)alkylsulphonyl groups;
- and aminocarbonyl wherein the amino group is optionally substituted by (C1-4)alkyl;
- R2 is hydrogen, or (C1-4)alkyl, or together with R6 forms Y as defined below;
- A is a group (ia) or (ib):
- in which:
- R3 is as defined for R1a or R1b or is oxo and n is 1 or 2:
- or A is a group (ii)
- W1, W2 and W3 are CR4R8
- or W2 and W3 are CR4R8 and W1 represents a bond between W3 and N.
- X is O, CR4R8, or NR6;
- one R4 is as defined for R1a and R1b and the remainder and R8 are hydrogen or one R4 and R8 are together oxo and the remainder are hydrogen;
- R6 is hydrogen or (C1-6)alkyl;
- or together with R2 forms Y;
- R7 is hydrogen;
- halogen;
- hydroxy optionally substituted with (C1-6)alkyl;
- or (C1-6alkyl;
- Y is CR4R8CH2;
- CH2CR4R8;
- (C═O);
- CR4R8;
- CR4R8(C═O);
- or (C═O)CR4R8;
- or when X is CR4R8, R8 and R7 together represent a bond;
- R5 is a group —X1a—X2a—X3a—X4a in which:
- X1a is CH2, CO or SO2;
- X2a is CR14aR15a;
- X3a is NR13a;
- O, S, SO2 or CR14aR15a;
- wherein:
- each of R14a and R15a is independently selected from:
- H;
- (C1-4)alkylthio;
- halo;
- carboxy(C1-4)alkyl;
- halo(C1-4)alkoxy;
- halo(C1-4)alkyl;
- (C1-4)alkyl;
- (C2-4)alkenyl;
- (C1-4)alkoxycarbonyl;
- formyl;
- (C1-4)alkylcarbonyl;
- (C2-4)alkenyloxycarbonyl;
- (C2-4)alkenylcarbonyl;
- (C1-4)alkylcarbonyloxyl ;
- (C1- 4)alkoxycarbonyl(C1-4)alkyl;
- hydroxy;
- hydroxy(C1-4)alkyl;
- mercapto(C1-4)alkyl;
- (C1-4)alkoxy;
- nitro;
- cyano;
- carboxy;
- amino or aminocarbonyl optionally substituted as for corresponding substituents in R3;
- (C1-4)alkylsulphonyl;
- (C2-4)alkenylsulphonyl;
- or aminosulphonyl wherein the amino group is optionally substituted by (C1-4)alkyl or (C2-4)allcenyl;
- aryl;
- aryl(C1-4)alkyl;
- aryl(C1-4)alkoxy;
- provided that R14a and R15a on the same carbon atom are not both selected from optionally substituted hydroxy and optionally substituted amino;
- or
- R14a and R15a together represent oxo;
- R13a is hydrogen;
- trifluoromethyl;
- (C1-6)allcyl;
- (C2-6)alkenyl;
- (C1-6)alkoxycarbonyl;
- (C1-6)alkylcarbonyl;
- or aminocarbonyl wherein the amino group is optionally substituted by (C1-6)alkoxycarbonyl, (C1-6)alkylcarbonyl, (C2-6)alkenyloxycarbonyl, (C2-6)alkenylcarbonyl, (C1-6)alkyl or (C2-6)alkenyl and optionally further substituted by (C1-6)alkyl or (C2-6)alkenyl;
- or
- two R14a groups or an R13a and an R14a group on adjacent atoms together represent a bond and the remaining R13a, R14a and R15a groups are as above defined;
- or
- two R14a groups and two R15a groups on adjacent atoms together represent bonds such that X2a and X3a is triple bonded;
- X4a is phenyl or C or N linked monocyclic aromatic 5- or 6-membered heterocycle containing up to four heteroatoms selected from O, S and N and:
- optionally C-substituted by up to three groups selected from (C1-4)alkylthio;
- halo;
- carboxy(C1-4)alkyl;
- halo(C1-4)alkoxy;
- halo(C1-4)alkyl;
- (C1-4)alkyl;
- (C2-4)alkenyl;
- (C1-4)allcoxycarbonyl;
- formyl;
- (C1-4)alkylcarbonyl;
- (C2-4)alkenyloxycarbonyl;
- (C2-4)alkenylcarbonyl;
- (C1-4)alkylcarbonyloxy;
- (C1-4)alkoxycarbonyl(C1-4)alkyl;
- hydroxy;
- hydroxy(C1-4)alkyl;
- mercapto(C1-4)alkyl;
- (C1-4)alkoxy;
- nitro;
- cyano;
- carboxy;
- amino or aminocarbonyl optionally substituted as for corresponding substituents in R3;
- (C1-4)alkylsulphonyl;
- (C2-4)alkenylsulphonyl;
- or aminosulphonyl wherein the amino group is optionally substituted by (C1-4)alkyl or (C2-4)alkenyl;
- aryl, aryl(C1-4)alkyl or aryl(C1-4)allcoxy;
- and
- optionally N substituted by trifluoromethyl;
- (C1-4)alkyl optionally substituted by hydroxy, (C1-6)alkoxy, (C1-6)alkylthio, halo or trifluoromethyl;
- (C2-4)alkenyl;
- aryl;
- aryl(C1-4)alkyl;
- (C1-4)alkoxycarbonyl;
- (C1-4)alkylcarbonyl;
- formyl;
- (C1-6)alkylsulphonyl;
- or aminocarbonyl wherein the amino group is optionally substituted by (C1-4)alkoxycarbonyl, (C1-4)alkylcarbonyl, (C2-4)alkenyloxycarbonyl, (C2-4)alkenylcarbonyl, (C1-4)alkyl or (C2-4)alkenyl and optionally further substituted by (C1-4)alkyl or (C2-4)alkenyl;
- and
- R9 is hydrogen or hydroxy, or when Z is N R9 may instead be fluoro.
124 more elements
13-15. (canceled)
Dependencies are inferred from the claim text.